5WOODBURN J R. The epidermal growth factor receptor and its inhibition in cancertherapy [J]. Pharmacol Ther, 1999, 82(2) : 241 - 250.
6HUNCHAREK M, KUPELNICK B.Epidermal growth factor receptor geneamplification as a prognostic marker in glioblastoma multiforme: results of a meta-analysls [J]. Oncol Bes, 2000, 12(2): 107 - 112.
7MAJUMDAR A P, DU J, HATFIELD J S,et al. Expression of EGF-receptor relatedprotein(EBB.P) decreases in gastric mucosa during aging and carciogenesls [J] . Dig Dis and Scl, 2003,48(5): 856-864.
8HENLEY J D, KOUKOULIS G K,LOEHRER P J S R. Epidermal growth factor receptor expression in invaslve thymoma [J]. J Cancer Res Clin Oneol,2002,128(3): 167 - 170.
9TSUTSUI S, KATAOKA, OHNO S, et al. Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer [J]. Clin Cancer Res ,2002,8(11 ): 3454 - 3460.
10PECINA-SLAUS N. Tumor suppressor gene E-cadhedn and its role in normal and malignant cells [J]. Cancer Cell Int,2003, 3(1): 17.
2Browning M, Petronzelli F, Bieknell D, et al. Mechanisms of loss of HLA class I expression on colorectal tumor cells [ J ]. Tissue-Anti- gens,1996,47 (5) :364 -371.
3Maharaj B, Khedun SM, Hammond MG. HLA-antigens in black pa- tients with hepatocellular carcinoma [ J]. Easr Afr Med J, 1997, 74( 11 ) :705 -707.
4Fukusato T,Gerber MA,Thung SN,et al. Expression of HLA class I antigens on hepatocytes in liver disease[J]. Am J Pathol, 1986, 123(2) :264 -270.
5Paterson AC, Sciot R, Kew MC, et al. HLA expression in human hep- atocellular carcinoma [ J ]. Br J Cancer, 1988,57 (4) : 369 - 373.
6Wang Y, Ye Z, Meng XQ, et al. Expression of HLA-G in patients with hepatoceUular carcinoma[ J ]. Hepatobiliary Pancreat Dis Int, 2011, 10(2) :158 - 163.
7Sung CH,Hu CP,Hsu HC,et al. Expression of class I and class I I major histocompatibility antigens on human epatocel-lular carcinoma [ J]. J Clin Invest, 1998,83 (2) :421 - 429.
8Garcia-lora A, Algarra I, Garrido F. MHC class I antigens, immune surveillance, and tumor immune escape [ J ]. J Cell Physiol, 2003, 195(3) :346 -355.
9Yoshida S, Hazama S,Tokuno K, et al. Concomitant overexpression of heat-shock protein 70 and HLA class-1 in hepatitis C virus-related hepatocellular carcinoma[ J ]. Anticancer Res, 2009,29 ( 2 ) : 539 - 544.
10Fujiwara K, Higashi T, Nouso K. Decreased expression of B7 costimu- latory molecules and major histocompatibility complex class-I in hu- man hepatocellular carcinoma [ J ]. J Gastroenterol Hepatol, 2004, 19(10) :1121 - 1127.
